Two drug molecules achieve myelin repair in MS disease models

BY THE OPTIMIST DAILY EDITORIAL TEAM Every remyelination drug candidate tested in multiple sclerosis research has failed. A doctoral thesis from the University of Helsinki, defended earlier this month, reports two that didn’t. Tapani Koppinen, working in Associate Professor Merja Voutilainen’s research group, identified two separate drug molecules that successfully triggered myelin regrowth in MS […] The post Two drug molecules achieve myelin repair in MS disease models first appeared on The Optimist Daily: Making Solutions the News.